1. Home
  2. RENX vs TIVC Comparison

RENX vs TIVC Comparison

Compare RENX & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$1.70

Market Cap

4.1M

Sector

N/A

ML Signal

N/A

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

HOLD

Current Price

$1.40

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
TIVC
Founded
2021
2016
Country
United States
United States
Employees
38
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RENX
TIVC
Price
$1.70
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.3K
222.5K
Earning Date
05-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.75
52 Week High
$3.48
$5.60

Technical Indicators

Market Signals
Indicator
RENX
TIVC
Relative Strength Index (RSI) 44.33 69.31
Support Level $1.40 $0.79
Resistance Level $2.21 $2.70
Average True Range (ATR) 0.17 0.11
MACD -0.04 0.03
Stochastic Oscillator 38.27 100.00

Price Performance

Historical Comparison
RENX
TIVC

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.

Share on Social Networks: